Neuland Laboratories Ltd. (NEULANDLAB) Share Price Rises 3.25% Today
- August 5, 2026
- Posted by: Harsh Piplani
- Category: News
Neuland Laboratories Ltd. Share Price is currently at Rs 19,915, reflecting a 3.25% increase today. The company’s market capitalisation stands at Rs 25,160.18 crore.
Neuland Laboratories Ltd. Share Price has seen a notable increase today, reaching Rs 19,915, up by 3.25% from the previous close of Rs 19,288.35. This price rise positions Neuland Laboratories Ltd. among the top gainers in the Healthcare sector. With a market capitalisation of Rs 25,160.18 crore, the company is classified as a Large Cap entity.
The current price action reflects a strong performance, with the stock opening at Rs 19,252.75 and reaching a high of Rs 19,920 during the day. The total volume traded today is 23,981 shares, indicating active participation in the market. The turnover for the day stands at Rs 3.01 crore, further highlighting the stock’s strong performance.
Neuland Laboratories Ltd. (NEULANDLAB) Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 19,915 |
| Previous Close | Rs 19,288.35 |
| Today's Change | +Rs 626.65 (+3.25%) |
| Day Open | Rs 19,252.75 |
| Day High | Rs 19,920 |
| Day Low | Rs 19,252.75 |
| Current Volume (BSE) | 1,509 |
| BSE Traded Volume | 1,509 |
| NSE Traded Volume | 22,472 |
| Combined NSE + BSE Volume | 23,981 |
| Turnover | Rs 3.01 crore |
| Market Capitalisation | Rs 25,160.18 crore |
| Market Cap Category | Large Cap |
Neuland Laboratories Ltd. (NEULANDLAB) traded at Rs 19,915. versus the previous close of Rs 19,288.35, a rise of 3.25%. The stock opened at Rs 19,252.75, reached Rs 19,920, touched Rs 19,252.75. Reported volume was 1,509.
Neuland Laboratories Ltd. (NEULANDLAB) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 25,160.18 crore |
Neuland Laboratories Ltd. operates within the Healthcare sector, with a market capitalisation of Rs 25,160.18 crore. The company’s valuation metrics, such as P/E and P/B ratios, provide insight into its financial standing.
The Healthcare sector’s P/E median is 26.29, with an average of 91.55, indicating a wide range of valuations within the sector. The P/B median is 1.9, with an average of 2.57. These benchmarks help assess Neuland Laboratories Ltd.’s relative valuation.
In terms of profitability, the sector’s ROE median is 10.77%, with an average of 15.33%, while the ROCE median is 13.35%, with an average of 17.69%. These figures provide a backdrop for evaluating the company’s financial performance.
Neuland Laboratories Ltd.’s market capitalisation places it well above the sector’s median of Rs 136.63 crore, highlighting its significant presence in the Healthcare industry. This context is crucial for understanding the company’s position and potential within the sector.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Benchmark Scope | same sector |
| Benchmark Median P/E | 26.29x |
| Benchmark Average P/E | 91.55x |
| Benchmark P/E Range | 3.39x to 3,385.56x |
| Benchmark Median P/B | 1.9x |
| Benchmark Median ROE | 10.77% |
| Benchmark Median ROCE | 13.35% |
| Company Market Capitalisation | Rs 25,160.18 crore |
| Benchmark Median Market Cap | Rs 136.63 crore |
Neuland Laboratories Ltd. (NEULANDLAB) is classified under sector: Healthcare.
Track today’s top gainers through the Univest top gainers screener. The peer table below provides the company-level comparison.
Neuland Laboratories Ltd. is part of the Healthcare sector, which comprises 198 companies. The sector’s P/E median is 26.29, with an average of 91.55, reflecting a diverse range of valuations. The P/B median is 1.9, with an average of 2.57, providing a benchmark for assessing company valuations.
The sector’s ROE median is 10.77%, with an average of 15.33%, while the ROCE median is 13.35%, with an average of 17.69%. These metrics offer insight into the sector’s profitability and efficiency.
Neuland Laboratories Ltd.’s market capitalisation of Rs 25,160.18 crore places it significantly above the sector’s median of Rs 136.63 crore, underscoring its substantial market presence. This context is essential for understanding the company’s competitive positioning within the Healthcare industry.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Dishman Carbogen Amcis Ltd. | DCAL | 2,945.17 | 30.21 | 0.44 | -2.89 | -0.26 |
| Hikal Ltd. | HIKAL | 2,835.92 | 0 | 2.35 | 15.22 | 16.15 |
| Kwality Pharmaceuticals Ltd. | KPL | 2,652.68 | 39.86 | 8.11 | 28.21 | 26.35 |
| Beta Drugs Ltd. | BETA | 2,608.51 | 63.2 | 10 | 18.65 | 22.17 |
| Panacea Biotec Ltd. | PANACEABIO | 2,589.99 | 0 | 3.07 | 0 | 5.36 |
Neuland Laboratories Ltd. (NEULANDLAB) has a market capitalisation of Rs 25,160.18 crore. Among the 5 peers shown, 0 have a larger market capitalisation.
Neuland Laboratories Ltd. operates in the Pharmaceuticals & Drugs industry, alongside peers such as Dishman Carbogen Amcis Ltd., Hikal Ltd., and Kwality Pharmaceuticals Ltd. These companies provide a benchmark for evaluating Neuland Laboratories Ltd.’s performance.
Dishman Carbogen Amcis Ltd. has a market capitalisation of Rs 2,945.17 crore, with a P/E of 30.21 and a P/B of 0.44. Hikal Ltd. has a market capitalisation of Rs 2,835.92 crore, with a P/B of 2.35. Kwality Pharmaceuticals Ltd. has a market capitalisation of Rs 2,652.68 crore, with a P/E of 39.86 and a P/B of 8.11.
These comparisons highlight Neuland Laboratories Ltd.’s relative strengths and weaknesses in terms of market capitalisation and valuation metrics. The company’s positioning within the industry is crucial for understanding its competitive landscape.
Why Investors Are Watching Neuland Laboratories Ltd.
Investors are closely monitoring Neuland Laboratories Ltd. due to its recent price rise and strong market presence. The company’s performance today has captured attention, and its position within the Healthcare sector adds to its appeal.
- Price Action: Neuland Laboratories Ltd. Share Price increased by 3.25% today, reaching Rs 19,915.
- Technical Position: The stock’s strong performance indicates positive momentum.
- Fundamental Context: The company’s market capitalisation and sector benchmarks provide valuable insights.
- Sector Positioning: Neuland Laboratories Ltd. is a significant player in the Healthcare sector.
Investors should continue to monitor Neuland Laboratories Ltd.’s performance, considering its market dynamics and sector trends. Understanding the company’s financial health and industry position will be crucial for making informed decisions.
About Neuland Laboratories Ltd.
Neuland Laboratories Ltd. is a prominent player in the Healthcare sector, specialising in the Pharmaceuticals & Drugs industry. The company is known for its expertise in manufacturing and supplying active pharmaceutical ingredients (APIs) to global markets. Neuland Laboratories Ltd. operates across various segments, focusing on research and development, production, and distribution of high-quality pharmaceutical products.
With a strong emphasis on innovation and quality, Neuland Laboratories Ltd. has established itself as a reliable partner for pharmaceutical companies worldwide. The company’s commitment to excellence and customer satisfaction has contributed to its reputation as a leading player in the industry.
Track Neuland Laboratories Ltd. Share Price on Univest
Use Neuland Laboratories Ltd. (NEULANDLAB) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top gainers lists and related market analysis.
Investors and analysts can track Neuland Laboratories Ltd. Share Price and other key metrics on Univest. The platform provides live updates on share price, technical indicators, fundamental ratios, and shareholding patterns. Users can also access insights into the company’s 52-week levels and market trends, making it a valuable resource for informed decision-making.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
What is the current share price of Neuland Laboratories Ltd.?
Ans. The current share price of Neuland Laboratories Ltd. is Rs 19,915, reflecting a 3.25% increase from the previous close. The stock moved 3.25% during the session. The intraday range extended from Rs 19,252.75 to Rs 19,920.
How much did Neuland Laboratories Ltd. share price rise today?
Ans. Neuland Laboratories Ltd. share price rose by 3.25% today, marking a significant gain in the Healthcare sector. The stock moved 3.25% during the session. The intraday range extended from Rs 19,252.75 to Rs 19,920.
How does Neuland Laboratories Ltd. compare to its peers?
Ans. Neuland Laboratories Ltd. is compared with peers like Dishman Carbogen Amcis Ltd. and Hikal Ltd., highlighting its market capitalisation and valuation metrics. Comparable listed companies include Dishman Carbogen Amcis Ltd., Hikal Ltd., Kwality Pharmaceuticals Ltd.
What is the P/E median for the Healthcare sector?
Ans. The P/E median for the Healthcare sector is 26.29, providing a benchmark for evaluating company valuations. The relevant peer median P/E is 26.29x. The peer average P/E is 91.55x. The stock belongs to the Healthcare sector.
How does Neuland Laboratories Ltd.'s market cap compare to the sector median?
Ans. Neuland Laboratories Ltd.'s market cap of Rs 25,160.18 crore is significantly above the sector median of Rs 136.63 crore. The company operates in the Healthcare sector. The stock belongs to the Healthcare sector.
